CO-AX Technology Inc

Form 483 issued August 2, 2023 · Solon, Ohio

Inspection
Jul 24 – Aug 2, 2023
Observations
9
Pages
8
FEI number
3013413442

In short: On August 2, 2023, FDA issued a Form 483 with 9 observations to CO-AX Technology Inc in Solon, Ohio (FEI 3013413442) after an inspection that ran Jul 24 – Aug 2, 2023. The investigators were Benjamin Dastoli and Melina L. Rodriguez-Upton. Most observations concern production & process controls and cAPA; the most-cited regulation is 21 CFR 820.90 (nonconforming product).

At a glance

Production & process controls and capa account for 9 of 9 observations.

Production & process controls5
CAPA4

What FDA observed

Preview: the opening words of each observation
  1. 01

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  2. 02

    Procedures for rework of nonconforming product…

  3. 03

    Procedures to ensure equipment is routinely calibrated have…

  4. 04

    Procedures for acceptance of incoming product have…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at CO-AX Technology Inc?

FDA listed 9 observations on this Form 483, mostly about production & process controls and cAPA. The most-cited regulation is 21 CFR 820.90 (nonconforming product). The opening words of each observation are shown on this page.

Who inspected CO-AX Technology Inc?

Benjamin Dastoli and Melina L. Rodriguez-Upton are named on this Form 483, for the inspection of Jul 24 – Aug 2, 2023. Each investigator has a profile showing what they cite most.

When was CO-AX Technology Inc inspected by FDA?

The inspection ran Jul 24 – Aug 2, 2023, and the Form 483 is dated August 2, 2023.

How do I get the full Form 483 for CO-AX Technology Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free